Can-Fite BioPharma Ltd. Financial Liabilities At Fair Value Through Profit Or Loss
Can-Fite BioPharma Ltd. (CANF) had Financial Liabilities At Fair Value Through Profit Or Loss of $4.33 million as of 2019-12-31, per its 20-F filed 2020-03-27.
Discontinued › Notes
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss · last filed 2020-03-27
- 2019-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $4.33M.
- 2018-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $2.19M.
- 2017-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $1.42M; Financial Liabilities At Fair Value Through Profit Or Loss as first filed $2.60M.
- 2016-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $4.21M.
| Period end | Financial Liabilities At Fair Value Through Profit Or Loss | Financial Liabilities At Fair Value Through Profit Or Loss as first filed |
|---|---|---|
| 2019-12-31 | $4.33M 20-F · filed 2020-03-27 | |
| 2018-12-31 | $2.19M 20-F · filed 2020-03-27 | |
| 2017-12-31 | $1.42M 20-F · filed 2019-03-29 | $2.60M 6-K · filed 2018-08-08 |
| 2016-12-31 | $4.21M 6-K · filed 2018-08-08 |